RCUS

Arcus Biosciences Stock Analysis

AI Rating

Neutral
  • Quality4/10
  • Growth↓ 0/10
  • Momentum↑ 8/10
Arcus Biosciences sales and earnings growth
RCUS Growth
Low
  • Revenue Y/Y↓ -8.75%
  • EPS Y/Y↓ -9.21%
  • FCF Y/Y↓ -174.56%
Arcus Biosciences gross and profit margin trends
RCUS Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -142.10%
  • ROIC↓ -44.90%
Arcus Biosciences net debt vs free cash flow
RCUS Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -41.5

Arcus Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗